共 122 条
- [1] Newton AD(2016)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality J Gastrointest Oncol 7 99-111
- [2] Bartlett EK(2019)A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: the American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis Surg Endosc 33 854-860
- [3] Karakousis GC(2020)Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review Eur J Cancer 127 76-95
- [4] Arjona-Sanchez A(1995)Peritonectomy procedures Ann Surg 221 29-42
- [5] Esquivel J(2020)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: technical considerations and the learning curve J Surg Oncol 122 85-95
- [6] Glehen O(2011)Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience Ann Surg 253 764-768
- [7] Passot G(2020)Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma Surg Endosc 34 4916-4923
- [8] Turaga KK(2021)Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis The PSOGI international collaborative registry Eur J Surg Oncol 47 1420-6
- [9] Labow D(2014)Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies Eur J Surg Oncol 40 957-962
- [10] Auer RC(2021)Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis Surg Endosc 35 1778-1785